Basic Information

Name: Yueyue Chen
(Oct 1983–）

Birth
Location: Unknown

Title: Unknown

Affiliation: Unknown

Honor: Unknown

Yueyue Chen received her Master and BSc degrees with preventive medicine from University of Jilin, China. She received her PhD degree with basic medical science from the University of Muenster, Germany, under the supervision of professor Lifeng Chi (Member of the Chinese Academy of Sciences). Currently, she worked at the Capital Medical University, China. Her research interest spans from functional supramolecular interface materials fabricate in general to the design and application in clinical medicine and preventive medicine.

1 Chen Yueyue#, Huang Zehuan#, Xu Jiang-Fei, Sun Zhiwei*, Zhang Xi*. Cytotoxicity regulated by host-guest interactions: a supramolecular strategy to realize controlled disguise and exposure. ACS Applied Materials & Interfaces, 2016, 8(35), 22780-22784.

2 Chen Yueyue#, Huang Zehuan#, Xu Jiang-Fei, Sun Zhiwei*, Zhang Xi*. Supramolecular chemotherapy: cooperative enhancement of antitumor activity by combining controlled release of oxaliplatin and consuming of spermine by cucurbit[7]uril. ACS Applied Materials & Interfaces, 2017, 9(10), 8602-8608.

3 Chen Hao#, Chen Yueyue#, Wu Han, Xu Jiang-Fei, Sun Zhiwei*, Zhang Xi*. Supramolecular polymeric chemotherapy based on cucurbit[7]uril-PEG copolymer. Biomaterials, 2018, 178, 697-705.

4 Huang Xin, Zhou Hang, Jiao Rong, Liu Hanrui, Qin Changfu, Xu Lixin, Chen Yueyue*. Supramolecular chemotherapy: host-guest complexes of heptaplatin-cucurbit[7]uril toward colorectal normal and tumor cells. Langmuir, 2021, 37(18), 5475-5482.

5 Hao Qi#, Chen Yueyue#, Huang Zehuan, Xu Jiang-Fei, Sun Zhiwei*, Zhang Xi*. Supramolecular chemotherapy: carboxylated pillar[6]arene for decreasing cytotoxicity of oxaliplatin to normal cells and improving its anticancer bioactivity against colorectal cancer. ACS Applied Materials & Interfaces, 2018, 10(6), 5365-5372.

6 Chen Yueyue*, Jing Li, Meng Qingtao, Li Bin, Chen Rui, Sun Zhiwei. Noncovalent bond synergy of cucurbit[7]uril against human colorectal tumor cells. Langmuir, 2021, 37(31), 9547-9552.

7 Liang Shuang#, Chen Yueyue#, Zhang Shiming, Cao Yuanyuan, Duan Junchao*, Wang Yapei*, Sun Zhiwei*. RhB-encapsulating silica nanoparticles modified with PEG impact the vascular endothelial function in endothelial cells and zebrafish model. Science of the Total Environment, 2020, 711, 134493.

8 Chen Yueyue, Sun Zhiwei*. Supramolecular chemotherapy based on the host-guest complex of lobaplatin-cucurbit[7]uril. ACS Applied Bio Materials, 2020, 3, 2449-2454.

9 Duan Junchao, Liang Shuang, Yu Yang, Li Yang, Wu Zehao, Chen Yueyue*, Miller Mark R, Sun Zhiwei*. Inflammation-coagulation response and thrombotic effects induced by silica nanoparticles in endothelial cells and zebrafish embryos. Nanotoxicology, 2020, 12(5), 470-484.

10 Zeng Zhaomu#, Chen Yueyue#, Geng Xiuchao, Zhang Yuhao, Wen Xichao, Yan Qingyu, Wang Tingting, Ling Chen, Xu Yan, Duan Junchao, Zheng Kebin*, Sun Zhiwei*. NcRNAs: multi-angle participation in the regulation of glioma chemotherapy resistance. International Journal of oncology, 2022, 60, 76.

11 Chen Yueyue, Zeng Guanghong, Pan Fei, Wang Junbo, Chi Lifeng*. Controlled assembly and release of retinoic acid based on the layer-by-layer method. Langmuir, 2013, 29(8), 2708-2712.

12 Hang Zhou, Qingtao Meng, Bin Li, Yikai Liu, Zhaoxiang Li, Xiaobo Li, Zhiwei Sun, Yueyue Chen*. Supramolecular combination chemotherapy: cucurbit[8]uril complex enhanced platinum drug infiltration and modified nanomechanical property of colorectal cancer cells. Langmuir, 2022. DOI: 10.1021/acs.langmuir.2c02388.

13 Yilin Li, Yuteng Su, Zhaoxiang Li, Yueyue Chen*. Supramolecular combination cancer therapy based on macrocyclic supramolecular materials. Polymers, 2022, 14(22), 4588.